ProMIS Neurosciences Inc expected to post a loss of 17 cents a share - Earnings Preview

ProMIS Neurosciences

04/08/2025 14:34

ProMIS Neurosciences Inc PMN.OQ PMN.O is expected to  show no change in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for ProMIS Neurosciences Inc is for a loss of 17 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for ProMIS Neurosciences Inc is $6.00, about 87.2% above its last closing price of $0.77

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.12
-0.21
Missed
-75
Dec. 31 2025
-0.12
-0.14
-0.01
Beat
92.9
Sep. 30 2024
-0.07
-0.07
0.42
Beat
700​
Jun. 30 2024
-0.14
-0.14
-0.13
Beat
7.1
​​Mar. 31 2024
-0.20
-0.19
Beat
5
Dec. 31 2023
-0.17
-0.29
Missed
-70.6​
Sep. 30 2023
-0.33
-0.33
-0.19
Beat
42.4

This summary was machine generated August 4 at 13:34 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)